ixazomib plus pomalidomide, dexamethasone in relapsed/refractory myeloma
Published 8 years ago • 1.1K plays • Length 6:07Download video MP4
Download video MP3
Similar videos
-
1:55
dr. mateos on ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
-
1:42
apollo: pomalidomide plus dexamethasone, with/without daratumumab in r/r mm
-
2:22
dr. voorhees on pomalidomide/dexamethasone/ixazomib triplet in multiple myeloma
-
7:43
ixazomib, pomalidomide and dexamethasone (ixpd) in rrmm characterized with high-risk cytogenetics
-
2:21
overview of the tourmaline-mm1 study in relapsed/refractory multiple myeloma
-
3:55
ixazomib benefit persists despite prior therapy in tourmaline-mm1 subset analysis
-
1:09
an update on alliance a061202: addition of ixazomib to pomalidomide-dexamethasone in r/r myeloma
-
2:38
daria: daratumumab with ixazomib and dexamethasone for r/r myeloma
-
4:19
tourmaline-mm3 and 4: ixazomib as maintenance therapy in myeloma patients
-
2:12
comment: addition of ixazomib to pomalidomide dexamethasone improves survival for mm patients
-
0:59
investigating the efficacy of twice weekly ixazomib plus pom-dex in r/r multiple myeloma
-
1:49
real world data of ixazomib in combination with lenalidomide and dexamethasome
-
0:58
the efficacy of ixazomib for the treatment of r/r myeloma
-
3:54
results from the ifm 2014-01 trial: pomalidomide, dexamethasone & ixazomib in high-risk r/r myeloma
-
2:30
isatuximab, pomalidomide, and dexamethasone for relapsed/refractory myeloma
-
11:35
ixazomib-lenalidomide-dexamethasone in routine clinical practice
-
1:41
elotuzumab plus pomalidomide and dexamethasone for multiple myeloma
-
0:55
the value of ixazomib in the treatment of older, frail patients with multiple myeloma
-
10:44
isatuximab plus pomalidomide/low-dose dex vs pomalidomide/low-dose dex in pts with rrmm (icaria-mm)